Commonwealth Equity Services’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$194K Sell
10,251
-3,360
-25% -$57K ﹤0.01% 4020
2025
Q4
$182K Sell
13,611
-939
-6% -$11.6K ﹤0.01% 4007
2025
Q3
$172K Sell
14,550
-1,905
-12% -$17.8K ﹤0.01% 3986
2025
Q2
$107K Sell
16,455
-1,837
-10% -$12.1K ﹤0.01% 4054
2025
Q1
$107K Sell
18,292
-3,200
-15% -$22.9K ﹤0.01% 3981
2024
Q4
$150K Buy
21,492
+1,928
+10% +$13.3K ﹤0.01% 3829
2024
Q3
$111K Sell
19,564
-5,402
-22% -$37.6K ﹤0.01% 3847
2024
Q2
$180K Buy
24,966
+114
+0.5% +$997 ﹤0.01% 3669
2024
Q1
$234K Buy
24,852
+8,322
+50% +$47.5K ﹤0.01% 3499
2023
Q4
$61K Sell
16,530
-421
-2% -$1.27K ﹤0.01% 3733
2023
Q3
$53K Buy
+16,951
New +$69.7K ﹤0.01% 3652
2022
Q4
Sell
-12,491
Closed -$43K 3757
2022
Q3
$43K Sell
12,491
-2,574
-17% -$24.7K ﹤0.01% 3504
2022
Q2
$144K Buy
15,065
+2,690
+22% +$34K ﹤0.01% 3296
2022
Q1
$206K Buy
12,375
+1,295
+12% +$22.5K ﹤0.01% 3316
2021
Q4
$229K Buy
11,080
+1,083
+11% +$34.6K ﹤0.01% 3187
2021
Q3
$361K Buy
9,997
+1,984
+25% +$85.8K ﹤0.01% 2746
2021
Q2
$418K Buy
+8,013
New +$421K ﹤0.01% 2603

Other funds holding DFTX

Commonwealth Equity Services's DFTX Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Definium Therapeutics (DFTX) stake by 25% in Q1 2026, selling an estimated $57K and leaving 10,251 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #4020.

Commonwealth Equity Services first reported a position in DFTX in Q2 2021 and has held it in 17 quarters since. The position peaked at $418K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Commonwealth Equity Services held 10,251 shares of Definium Therapeutics worth $194K as of Q1 2026.
  • Commonwealth Equity Services sold 3,360 Definium Therapeutics shares in Q1 2026, an estimated $57K.
  • Definium Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #4020 holding.
  • Commonwealth Equity Services first reported a position in Definium Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Commonwealth Equity Services's Definium Therapeutics position peaked at $418K in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.